KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,220,000 | -28.0% | 60,000 | -45.5% | 0.89% | -34.7% |
| Q1 2017 | $8,634,000 | +140.7% | 110,000 | +37.5% | 1.37% | +98.7% |
| Q4 2016 | $3,587,000 | -99.9% | 80,000 | -11.1% | 0.69% | -13.8% |
| Q3 2016 | $5,027,400,000 | +143540.0% | 90,000 | +28.6% | 0.80% | +28.3% |
| Q2 2016 | $3,500,000 | +10.3% | 70,000 | +22.8% | 0.62% | +22.9% |
| Q3 2015 | $3,174,000 | -21.1% | 57,000 | -13.6% | 0.51% | +4.8% |
| Q2 2015 | $4,024,000 | +55.0% | 66,000 | +46.7% | 0.48% | +10.3% |
| Q1 2015 | $2,596,000 | +28.6% | 45,000 | +28.6% | 0.44% | -25.1% |
| Q4 2014 | $2,018,000 | – | 35,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |